Neurostimulation Market

Adoption of technologically advanced products, increase in requirement for minimal invasive surgery, and surge in aging population also powers the development of the neurostimulation devices market as they are more vulnerable to neurological disorders, such as Parkinson’s disease, Epilepsy, chronic pain, and Alzheimer’s disease.

Scope of The Report: Neurostimulation is an electrical procedure of inhibiting, stimulating, regulating, modifying, and changing the activity in the human body in the autonomous, central, or peripheral nervous system. Neurostimulation machines send electrical impulse close to the spine area wherein these signals jam the pain signals from getting to the brain. These machines offer electrical stimulation to the person’s spinal cord, brain, and peripheral nervous system.

Neurostimulation machines are specifically employed for the cure of neurological disorders such as chronic pain, epilepsy, depression, Parkinson’s disease, and other diseases. Development in the neurological techs is offering relief to the people having neurological and psychiatric disorders.

The neurostimulation devices market is divided by application, device type, region, and end user. By device type, the neurostimulation devices market is segmented into external and implantable devices. The implantable devices comprise vagus nerve stimulators, deep brain stimulators, sacral nerve stimulators, spinal cord stimulators, gastric electric stimulators, and others. The external devices comprise transcutaneous electrical nerve stimulator and transcranial magnetic stimulator. By application, the market is divided into urinary & fecal incontinence, essential tremor, Parkinson's Disease, Gastroparesis, depression, and others.

By end user, the market is divided into hospitals, rehabilitation centers, and medical clinics. By region, it is divided across Europe, North America, LAMEA, and Asia Pacific.

Neurostimulation Companies: The major players included in the global neurostimulation market forecast are, Boston Scientific Corporation, NeuroSigma, Inc., Cochlear Ltd., LivaNova PLC., Medtronic, Endostim Inc., Aleva Neurotherapeutics SA, Autonomic Technologies, BioControl Medical, Synapse Biomedical Inc., NeuroPace Inc., Electro Medics,

Neuros Medical, Nevro Corporation, ElectroCore, NeuroMetrix, ElectroCore LLC, Neuronetics Inc., EnteroMedics Inc., and SPR Therapeutics.

Neurostimulation Market Key Segments:

By Product Type: • • • • •

Spinal Cord Stimulators Deep Brain Stimulators Sacral Nerve Stimulators Vagus Nerve Stimulators Gastric Electric Stimulators

By Application Type: • • • • • • • •

Pain Management Epilepsy Essential Tremor Urinary and Fecal Incontinence Depression Dystonia Gastroparesis Parkinson's Disease

Others Increase In Occurrence Of Lifestyle Diseases And Investment For Neurological R&D Power The Development Of The Global Neurostimulation Devices Market Increase in occurrence of lifestyle diseases such as chronic pain and depression, investment for neurological R&D, and increase in number of neurological disorders are the factors that power the development of the global neurostimulation devices market.

Furthermore, adoption of technologically advanced products, increase in requirement for minimal invasive surgery, and surge in aging population also powers the development of the neurostimulation devices market as they are more vulnerable to neurological disorders, such as Parkinson’s disease, Epilepsy, chronic pain, and Alzheimer’s disease. The major hurdles for the development of the neurostimulation devices market are side effects such as tingling or prickling of the skin and allergic reaction

due to implantation of neurostimulation machines into the body and rise in device price. On the other hand, the accessibility of other treatment alternatives such as surgeries and drug therapies limit the development of the market.

Market by Regional Analysis North America • •

U.S. Canada

Europe • • • • • • • • • • •

Germany France U.K. Italy Spain Sweden Netherland Turkey Switzerland Belgium Rest of Europe

Asia-Pacific • • • • • • • • • • •

South Korea Japan China India Australia Philippines Singapore Malaysia Thailand Indonesia Rest Of APAC

Latin America •

Mexico

• • • • •

Colombia Brazil Argentina Peru Rest of South America

Middle East and Africa • • • • •

Saudi Arabia UAE Egypt South Africa Rest Of MEA

North America Added Up For The Biggest Income Share Earlier And Is Expected To Sustain The Lead During The Coming Years North America added up for the biggest income share earlier and is expected to sustain the lead during the coming years. On the other hand, strict government laws and increase in the average number of days needed in the FDA approval procedure might hinder region’s development. Europe follows North America, in terms of income share. Rapid economic growth in the Eastern European nations is predicted to pace this development further. In addition to this, since attaining a CE approval is simpler over an FDA approval, the production penetration is comparatively more in the region.